US HEVA Oncology and Rare Team Lead

Sanofi•Cambridge, MA

13d•Hybrid

About The Position

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. Sanofi is committed to advancing breakthroughs in cancer care and rare diseases, expanding scientific understanding and improving outcomes for patients facing serious, often life-threatening conditions. Through a focused and growing portfolio of innovative therapies, Sanofi aims to address critical gaps in care and deliver meaningful, potentially transformative treatment options for underserved patient communities. We are one bold HEOR team leveraging innovative HEOR to transform patient care and access. As HEOR experts, we lead the generation and dissemination of robust, business-relevant evidence to demonstrate value and drive access to medicines. The HEVA organization is driven by five core values that define how we work and deliver impact: One Team — Partnering without boundaries Bold Purpose — Pursuing ambitious, measurable goals Scientific Excellence with Relevance — Deep technical expertise Innovation in Action — Transforming how we research and deliver Impact for People — Creating meaningful outcomes for patients, the healthcare ecosystem, and our colleagues.

Requirements

Minimum 10 years of experience in health economics, outcomes research, or a related field.
Advanced degree (PhD, PharmD, or equivalent) in health economics, epidemiology, public health, economics, or related field required.
Demonstrated expertise in health economic modeling, real-world evidence generation, and outcomes research methodologies.
Deep expertise in US healthcare, payer dynamics, and policy, with a track record of translating evidence into strategic impact.
Proven track record of successful market access and reimbursement support through HEVA evidence and ability to influence decision-making at the highest levels of the organization using HEVA-developed insights and evidence.
Strong command of US evidence dissemination (HCEI/PIE, reactive/proactive, CFL, AMCP dossiers).
Exceptional leadership skills with demonstrated ability to inspire, motivate, and develop high-performing teams.
Strong change management capabilities and experience leading organizational transformation initiatives.
Proven ability to influence and collaborate effectively across all organizational levels and functions.
Extensive experience in oncology or rare therapeutic areas required, including deep understanding of disease pathophysiology, treatment paradigms, and market dynamics.
Strong written and verbal communication skills in English.
Ability to synthesize complex data into clear, actionable insights and strategic recommendations.

Responsibilities

Leads US HEOR strategy and execution for Oncology and Rare Therapeutic Areas (TAs) across indications, leading a team in ensuring the generation, translation, and dissemination of high-quality, decision-relevant evidence to impact access in the United States.
Drive measurable business impact through strategic US HEVA initiatives that directly support US commercial objectives and US market access goals compliantly and efficiently.
Develop and execute comprehensive US HEVA strategies that maximize product value propositions and competitive positioning, ensuring alignment with Global HEVA strategy.
Partner with commercial teams to translate HEVA insights into actionable business strategies.
Drive development of business-relevant US research agendas and strategies through cross-functional input and alignment.
Provide exceptional leadership to the US Oncology and Rare HEVA team, fostering a culture of excellence, innovation, and impact-driven performance.
Mentor and develop team members to build world-class HEVA capabilities within the organization.
Drive organizational change and process improvements to enhance team effectiveness and business impact.
Represent HEVA with US Oncology and US Rare Franchise Leadership Teams.
Build and maintain strong relationships with cross-functional teams to ensure pricing and access decisions and brand strategies are supported with demonstrable value of assets per robust evidence packages including real-world evidence.
Align closely with the Global HEVA team to ensure inclusion of US insights into global strategic plans and coordinate evidence generation, modelling, and evidence synthesis activities.
Deliver compelling presentations to senior leadership, including C-suite executives and US leadership teams.
Communicate complex health economics concepts and strategic recommendations to senior stakeholders with clarity and impact.
Influence key business decisions through data-driven insights and strategic HEVA recommendations.
Ensure clinical development plans are designed to deliver true differentiation aligned to Sanofi Oncology and Rare portfolio ambitions.
Oversee the design, execution, publication, and further dissemination of high-quality health economics and outcomes research studies to ensure the highest quality of evidence is delivered to support business objectives.
Develop comprehensive real-world evidence strategies that support product lifecycle management.
Ensure scientific rigor and regulatory compliance across all HEVA research activities.
Manage the development of US launch strategies and evidence generation plans, providing strategic HEVA input into Integrated Evidence Generation Plans (IEGPs) to ensure alignment across clinical, real-world evidence, and value demonstration objectives.
Compliantly lead efforts to further HEOR dissemination, application, and proactive and/or promotional use with US stakeholders (e.g., HCEI, PIE, consistent with FDA label).
Partner with Medical Affairs and Value & Access to ensure appropriate use of evidence in field communications and training.
Partner with Access Strategy teams and US Market Access teams to execute on innovative payer partnership health economics and outcomes research studies and analytics aligned with franchise priorities.
Build and maintain strategic relationships with key external stakeholders, including payers, health technology assessment bodies, and academic institutions.
Represent Sanofi at major scientific conferences and industry forums.
Collaborate with external research partners and key opinion leaders to advance HEVA science.
Support external engagement with key external evidence bodies (e.g., ICER, PDAB, IRA) on related pricing and access challenges, and evolving reimbursement frameworks.
As a leader in Sanofi's HEVA organization, seek opportunities to actively participate and engage with external professional HEOR societies.